Early Colorectal Cancer Management
Early cancer can be considered to be malignant disease confined to the muscularis propria of the colon or rectum. The real challenge in early cancer is to differentiate those patients who truly have early disease from those with a primary tumor confined to the bowel wall and metastatic disease. The challenge is significant because in early cancer, nodal metastatic disease is often microscopic. If we were able to exclude metastatic disease, treatment decisions would be relatively simple. If the lesion were excised luminally, by polypectomy, EMR or TEMS, the only consideration post resection would be whether there was an adequate excision margin on histological examination.
KeywordsLocal Excision Lymphovascular Invasion Transanal Endoscopic Microsurgery Muscularis Propria Early Cancer
- 2.Atkin WS, Cook CF, Cuzick J, Edwards R, Northover JM, Wardle J, UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet. 2002;359:1291–300.PubMedCrossRefGoogle Scholar
- 6.Brown SR, Baraza W. Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum. Cochrane Database Syst Rev. 2010;(10):CD006439.Google Scholar
- 10.Royal College of Pathologists Dataset Standards and Datasets for Reporting Cancers. Dataset for colorectal cancer, 2nd edn. 2007. http://www.rcpath.org/resources/pdf/G049-ColorectalDataset-Sep07.pdf.